|
HS Code |
850464 |
| Name | Nicotine |
| Chemical Formula | C10H14N2 |
| Molecular Weight | 162.23 g/mol |
| Appearance | Colorless to yellow, oily liquid |
| Melting Point | -79 °C |
| Boiling Point | 247 °C |
| Solubility In Water | Miscible |
| Density | 1.01 g/cm3 |
| Cas Number | 54-11-5 |
| Pka | 8.02 |
| Iupac Name | 3-[(2S)-1-methylpyrrolidin-2-yl]pyridine |
As an accredited Nicotine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Amber glass bottle, tightly sealed with child-resistant cap, hazard labels clearly displayed. Contains 100 mL nicotine solution, concentration prominently marked. |
| Shipping | Nicotine is classified as a hazardous material for shipping. It must be packed in tightly sealed, labeled containers that comply with local, national, and international regulations. Appropriate documentation, hazard communication, and handling instructions are required. Shipment must be via authorized carriers, and special provisions may apply due to nicotine’s toxic and flammable nature. |
| Storage | Nicotine should be stored in a tightly closed container, in a cool, dry, well-ventilated area away from heat, sparks, open flames, and incompatible substances such as strong oxidizers and acids. It should be kept in a secure, locked location, clearly labeled, and protected from direct sunlight. Personal protective equipment is necessary when handling to prevent accidental exposure or inhalation. |
|
Purity 99%: Nicotine Purity 99% is used in pharmaceutical research, where it ensures consistent pharmacological activity in controlled studies. Molecular Weight 162.23 g/mol: Nicotine Molecular Weight 162.23 g/mol is used in analytical calibration, where it provides accurate quantification in chromatographic methods. Stability Temperature 25°C: Nicotine Stability Temperature 25°C is used in e-liquid formulation, where it maintains chemical integrity during storage. Liquid State: Nicotine Liquid State is used in industrial synthesis of insecticides, where it allows effective blending and solubility in processing. Melting Point −79°C: Nicotine Melting Point −79°C is used in cryopreservation technologies, where it offers enhanced product handling without premature solidification. Assay (HPLC) ≥98%: Nicotine Assay (HPLC) ≥98% is used in quality control laboratories, where it guarantees reproducibility and reliability of test results. Particle Size <10 µm: Nicotine Particle Size <10 µm is used in transdermal patch formulation, where it promotes uniform release and absorption rates. Residual Solvent <0.5%: Nicotine Residual Solvent <0.5% is used in oral nicotine pouches, where it minimizes potential impurity exposure to consumers. Optical Rotation −169°: Nicotine Optical Rotation −169° is used in stereochemical analysis, where it assists in verifying enantiomeric purity for regulatory compliance. Vapor Pressure 0.042 kPa: Nicotine Vapor Pressure 0.042 kPa is used in aerosol research, where it optimizes vaporization efficiency for inhalation products. |
Competitive Nicotine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Every conversation about nicotine tends to split the room. Some folks picture tobacco leaves and cigarettes, others see a white powder vaped through modern devices, and there’s a growing crowd that knows it only from news stories debating its role in public health. Let’s drop the medical jargon and talk straight about what nicotine actually represents today.
Nicotine, at its simplest, is a naturally occurring compound found in the nightshade family—think tobacco, tomatoes, potatoes, and eggplants. When isolated for commercial use, especially in products like e-liquids, nicotine salts, and replacement therapies, manufacturers usually produce a purified, pharmacopeia-grade substance. Industry calls it by model numbers like nicotine 99+ or nicotine 100, which refer to its percentage of purity, usually upwards of 99%.
So, what’s the big deal with purity in nicotine? Most of the stories about harshness or off-putting flavor in older smoking cessation products came down to impurities and inconsistent concentration. With today’s production processes, nicotine reaches levels of 99.5% purity or more. That shift not only makes dosing more predictable—it steers clear of substances that can throw off taste or cause irritation. Whether it lands in a nicotine gum or fills up a pod vape, what you get is consistent, measured amounts. It’s a pretty far cry from the tar-filled solutions of the previous century.
Let’s look at the physical side. Pure nicotine stands as a colorless, oily liquid at room temperature. It boasts a sharp, distinctive taste and a strong odor, but those don’t always carry through into the final consumer products. The important part: this stuff is potent. A tiny amount goes a long way, which is why manufacturers dilute it for safe handling and accurate dosing. For example, e-liquids might use concentrations like 3mg/ml, 6mg/ml, or higher, making it easy for users to control the level in their own routines.
There’s no denying the draw of nicotine. Human brains latch onto it, fast. It acts as a stimulant, binding to receptors and triggering a release of dopamine and other chemicals that light up the pleasure circuits. A cup of coffee does something similar with caffeine, but nicotine’s effect feels quicker and, to many, more pronounced. That’s why users often say it helps them concentrate, take the edge off stress, or just settle into a moment of calm.
Yet, with all that benefit comes a significant risk: dependence. I’ve seen people use nicotine patches to quit cigarettes, only to find that swapping one habit for another isn’t so simple. The cycle of urge, reward, and relief runs deep, and anyone who’s tried to quit will tell you that willpower alone rarely wins. According to public health data, about 70% of daily smokers want to quit, but only a small portion manage to do so in any given year. That underscores a truth about nicotine—its effects aren’t just in the mind; they change behavior, often in ways people don’t expect.
Anyone researching nicotine will find themselves surrounded by a crowd of alternatives and delivery methods. The differences between them matter more than most people realize. Inhalers, gums, and patches all release nicotine at different speeds and in different ways. Take vaping liquids for example: nicotine salts, a more recent innovation, allow people to inhale higher concentrations with less throat irritation. Freebase nicotine—the older form—delivers a punch but feels harsher on the lungs and throat at higher doses.
Leave aside the devices for a moment and consider pharmaceutical grade nicotine—used for research, smoking cessation therapies, and sometimes even agriculture. Unlike the crude extracts of old, pharmaceutical grade implies tight controls and repeated testing for consistency. By sourcing nicotine with a named standard (like USP or EP), manufacturers and researchers alike avoid contamination from heavy metals or pesticide residues picked up during farming or extraction.
The next big player is synthetic nicotine. Labs now produce nicotine without touching a tobacco plant, building its molecules from simple chemical building blocks. Some claim this sidesteps certain regulatory restrictions that focus on tobacco-derived nicotine. The controversy isn’t settled, but one thing is clear: chemically, synthetic and plant-derived nicotine are essentially identical, with subtle differences in isomer ratios that may or may not affect the user experience. Many companies blend synthetic and traditional sources, looking for smoother taste or more consistent performance, though most consumers can’t tell the difference.
The image of nicotine usually carries a lot of baggage. Years of anti-smoking campaigns have painted it as the villain behind cancer statistics, but the science sets things straight: nicotine creates the addiction, but it’s not the chief cause of smoking-related cancer or heart disease. Those come from the combustion of plant matter and a storm of chemicals produced in the process. That doesn’t give nicotine a free pass. While it doesn’t stain lungs with tar, nicotine’s stimulant effect can drive up heart rates and blood pressure. For people with certain heart conditions or adolescents with developing brains, this risk can add up.
As far as I’ve watched policy evolve, public health authorities walk a complicated line. They see nicotine as an opportunity—helping people move away from combustion, picking up e-cigarettes or gums—while also warning of its risks, especially for new users or the young. Regulation tries to fence off the most dangerous uses, like highly concentrated liquids or vending-flavored products in ways that tempt kids. I’ve seen this create a patchwork of laws: some places treat nicotine liquid as a medical product, others as a consumer good, and still others as a controlled substance.
Drawing on decades of research and my own observations, here’s what sticks. Nicotine remains one of the most widely used psychoactive substances worldwide. According to the World Health Organization, over a billion adults smoke tobacco, and hundreds of millions have tried at least one nicotine replacement product. E-cigarettes now outsell some forms of nicotine gum in the United States and Europe, showing that convenience and a familiar “hand-to-mouth” ritual matter just as much as chemistry in shifting habits.
Safety stories about nicotine sometimes get lost in the rhetoric. Acute poisoning is rare but real; hospital data reports serious consequences, especially in small children who get into concentrated liquids. Most adults aren’t in danger from accidental skin contact—a quick wash under running water takes care of minor spills—but it pays to treat pure or high-concentration formulations with real caution. Manufacturers use childproof bottles, stark warning labels, and, increasingly, traceability systems so people know exactly what they’re getting.
In the lab, nicotine isn’t just for helping people quit smoking. Scientists study its effects on memory, learning, and even the gut microbiome. Some research hints at possible future therapies for diseases like Parkinson’s, where nicotine’s effect on neural receptors offers a potential benefit. So far, these applications remain the subject of ongoing trials.
Let’s get practical. For most adults, nicotine comes packaged in a product: cigarettes, heated-tobacco sticks, e-liquid bottles, patches stuck under sleeves, pastilles, or chewing gum slipped discreetly into a pocket. The product’s form changes everything about the experience. Patches deliver a slow and steady trickle, which tends to curb cravings without the familiar buzz. Gums and lozenges provide bursts as they dissolve, making it easier to tailor a dose in the moment, especially during stressful events. Inhalers and e-cigarettes arrive the fastest, usually within seconds of a deep breath, mimicking the payoff of smoking more closely than anything else.
Personally, I’ve watched friends switch to e-cigarettes because they wanted to cut down on smoking or get rid of the smell. In most cases, the switch made the habit easier to control and the frequency easier to track. Vaping doesn’t appeal to everyone; some people find the devices fiddly, dislike the vapor, or are wary of the unknowns over long-term use. For those who stick to it, the ability to gradually lower their nicotine concentration—3mg to zero over time—often opens a door that cigarettes slammed shut.
Nicotine isn’t a one-product affair. Cigarette tobacco contains thousands of other substances, many of them dangerous when burned. Nicotine gum, on the other hand, skips combustion completely. Each delivery method shapes absorption into the bloodstream, the intensity of the experience, and the time it takes to feel the effect. E-liquids, especially those using nicotine salts, tend to offer the smoothest and fastest transitions for people moving away from smoking.
Price and access vary hugely. Over-the-counter gums and lozenges show up in pharmacies around the world, but high-strength e-liquids or pure nicotine products might require a prescription—or face legal barriers outright, especially in regions trying to prevent youth uptake. In my experience, ease of purchase often influences which path users choose.
Another point worth raising is the presence of unregulated black market products. Whenever lawmakers tighten controls, especially on flavored nicotine liquids, illegal imports almost always fill the gap. That undermines safety, leading to products with unknown strengths, questionable ingredients, or completely missing safety features. Consumer education makes a big difference here; knowing how to spot a legitimate, properly labeled bottle matters just as much as the label itself.
The reasons stretch far beyond addiction. Older adults often mention habit and stress relief, built up over decades of routine. Young adults—especially college students—talk about focus, appetite suppression, or social bonding. In some cultures, older forms like snus or chewing tobacco carry traditional or even ceremonial meaning. Across all these groups, perceptions have shifted as science and social policy have changed.
Nicotine products hold a paradox: they often serve as tools for people aiming to reduce the harm from smoking, even as some forms pose their own set of risks. I’ve seen families buy nicotine patches for grandparents finally ready to stop after years of heavy smoking. At the same time, news reports of adolescents caught vaping in school bathrooms highlight a growing concern: access and exposure among kids.
Public health players now embrace the idea of harm reduction—helping people use safer forms of a substance rather than pushing for outright abstinence. Importantly, studies from the United Kingdom and New Zealand support the idea that switching to e-cigarettes or gums carries dramatically lower risks than continued smoking. The Royal College of Physicians found that long-term e-cigarette use is unlikely to exceed five percent of the risk posed by smoking tobacco. That doesn’t mean these products come without risk—just that the context matters.
One answer rarely fits all. Some users step down their nicotine dependence dose by dose. Others find themselves caught in a new kind of cycle, using more than they intended and running into unexpected consequences, like increased heart rate, trouble sleeping, or, occasionally, nicotine toxicity from mishandled products. This creates an ongoing challenge for health education: teaching people both the advantages and the real downsides, without tipping into scare tactics or baseless reassurances.
There’s no magic fix for nicotine’s complex role in society. Better regulation, smarter packaging, and honest conversations about what each product really offers work together to shape the safest environment. Having spent time in both retail and healthcare environments, I’ve seen that people respond best to practical steps, not blanket bans or lectures. Clear labeling on products—where the nicotine came from, how much each bottle or patch contains, how to store it safely—makes a real difference in both trust and safety.
On the social level, support groups, easy-to-access quitlines, and both digital and in-person counseling close the gap between intent and action. I watched one friend succeed in quitting because his cessation program included not just patches and instructions, but regular check-ins and a community of others trying the same thing. Personalized plans matter—a fact endorsed by every major health authority I’ve ever worked with.
Another promising area: tax and pricing strategies. Higher prices deter youth uptake, especially with products aimed at first-time users. At the same time, subsidies or vouchers for quit aids like patches or gum make it easier for long-term smokers to try something new. Not all countries have figured out a balance, but every step that brings down smoking rates without driving people to illegal sources counts as progress.
For nicotine solutions to keep improving, ongoing research remains crucial. That includes honest studies of both the short-term and long-term effects of new formulations, user testimonials, and transparent tracking of reported side effects. It’s not glamorous work, but it keeps people informed and draws a line between fact, opinion, and untested claims.
The story of nicotine stretches from ancient herbal remedies to today’s sleek vapor devices and discreet gums. The modern product reflects decades of chemistry, medical science, and changing attitudes. The important thing to remember isn’t just the substance itself, but how people interact with it—their reasons, their risks, and the real-world effects on health and society.
On a good day, a well-made nicotine product helps someone step closer to quitting smoking or gets them through a tough morning with a little more control over their habit. On a bad day, misuse or mislabeling sends users down the wrong path, reinforcing addiction or posing unexpected dangers.
We’re in a better place than ever to make these decisions with our eyes wide open. As new types and delivery methods roll out, attention to quality, honest labeling, and community-level support will keep users safe and help future generations decide for themselves where nicotine does—and doesn’t—fit in their lives.